Drug intelligence / Profile preview

chicken anemia virus strain FAR-0023-17 vaccine

Development stage
Unknown
Lead developer
FARVET
Modality
Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular, Drinking Water
01

Overview

FARVET's Chicken Anemia Virus (CAV) vaccine is a live-attenuated, lyophilized viral vaccine derived from the FAR-0023-17 strain. It is specifically developed for the prevention of Chicken Infectious Anemia (CIA), a disease caused by the Gyrovirus genus of the Anelloviridae family. The vaccine works by inducing active immunity in chickens, typically administered to breeders to provide maternal antibodies to their progeny or to young birds to prevent clinical disease. The FAR-0023-17 strain is a specific isolate used by FARVET to ensure high immunogenicity and protection against local and international strains of the virus.

Brand names
CAV FAR
Other names
Chicken Infectious Anemia vaccineCAV vaccineFAR-0023-17-live lyophilized vaccineFAR0023-17-live lyophilized vaccineFAR 0023-17-live lyophilized vaccine

Beyond the preview

Go deeper on chicken anemia virus strain FAR-0023-17 vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chicken anemia virus strain FAR-0023-17 vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call